According to Supernus Pharmaceuticals 's latest financial reports and stock price the company's current Operating Margin is 14.78%. At the end of 2024 the company had an Operating Margin of 14.79%.
Year | Operating Margin | Change |
---|---|---|
2024 | 14.79% | 3144.52% |
2023 | 0.46% | -94.99% |
2022 | 9.10% | -27.87% |
2021 | 12.62% | -61.05% |
2020 | 32.41% | -13.7% |
2019 | 37.55% | 9.54% |
2018 | 34.28% | 2.98% |
2017 | 33.29% | 42.1% |
2016 | 23.43% | 136.46% |
2015 | 9.91% | -189.19% |
2014 | -11.11% | -98.55% |
2013 | -767.73% | -75.45% |
2012 | -3,127.30% | -36.38% |
2011 | -4,915.32% | -86.8% |
2010 | -37,239.62% | -341403.21% |
2009 | 10.91% | -102.9% |
2008 | -376.67% | -7.69% |
2007 | -408.04% |
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.